Infratil Limited (ASX:IFT)
10.70
-0.40 (-3.60%)
Jul 31, 2025, 4:10 PM AEST
Theseus Pharmaceuticals Market Cap
Infratil has a market cap or net worth of 10.45 billion as of July 31, 2025. Its market cap has increased by 12.01% in one year.
Market Cap
10.45B
Enterprise Value
18.06B
Revenue
3.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.70
Market Cap Chart
Since September 4, 1995, Infratil's market cap has increased from 88.25M to 10.45B, an increase of 11,736.37%. That is a compound annual growth rate of 17.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 30, 2025 | 10.78B | -2.39% |
Dec 31, 2024 | 11.04B | 42.31% |
Dec 29, 2023 | 7.76B | 32.82% |
Dec 30, 2022 | 5.84B | 7.14% |
Dec 31, 2021 | 5.45B | 10.73% |
Dec 31, 2020 | 4.92B | 54.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Transurban Group | 42.46B |
Brambles | 31.80B |
SGH Limited | 21.14B |
Qantas Airways | 16.27B |
ALS Limited | 9.15B |
Reece | 8.80B |
Qube Holdings | 7.69B |
Atlas Arteria | 7.52B |